This site is intended for healthcare professionals only
LoginRegister
Pfizers Abrocitinib Phase III Data Accepted by CDSCO Expert CommitteePfizer completes acquisition of Metsera
Sanofi gets approval for 2 rare hematologic diseases medicines in ChinaSanofi Teizeild recommended for EU approval by CHMP for stage 2 type 1 diabetes
Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosisDr Reddy's Told to Justify Patient Numbers in Vonoprazan Phase IV Trial, Revise Protocol
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreMerck to acquire Cidara Therapeutics for USD 9.2 billion
Unrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modis InterventionAIOCD Condemns Illegal Trade of Narcotic Cough Syrups
NPPA Finally Allows GSK to Discontinue Grisovin FPAfter Years of Resistance, NPPA Finally Allows GSK to Discontinue Grisovin FP
Lupin Nagpur facility completes USFDA inspectionLupin Nagpur facility completes USFDA inspection
Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2
Aurobindo Pharma arm Rajasthan facility gets 9 USFDA observationsAurobindo Pharma arm Rajasthan facility gets 9 USFDA observations
USFDA Approves Bionpharmas Generic HIV Drug EtravirineAlembic Pharma gets USFDA nod for angina drug Diltiazem Hydrochloride
USFDA concludes inspection with no 483 observations at Divis Labs Telangana facilityUSFDA concludes inspection with no 483 observations at Divi's Labs Telangana facility
USFDA concludes inspection at Dr Reddys Labs Srikakulam API facilityUSFDA concludes inspection at Dr Reddy's Labs Srikakulam API facility
X